Forbes Medi-Tech Sells Andro Business

VANCOUVER, British ColumbiaForbes Medi-Tech Inc. (NASDAQ:FMTI)sold its pharmaceutical fine chemicals business, which focused on processtechnologies for androstenedione and androstadienedione, to an unnamedmulti-national pharmaceutical company. The sale gave the company $1.9 million ingross proceeds. This initiative is in line with Forbes streamlined focus ongenerating revenue for its nutraceutical business.

For more information, visit www.forbesmedi.comor Booth #4807 at the IFT Food Expo.